BioXcel Therapeutics Inc BTAI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/02/23 EST
30.14UNCH (UNCH)
Volume
16,378
Close
30.14UNCH (UNCH)
Volume
411,385
52 week range
8.80 - 32.96
Loading...
  • Open29.58
  • Day High30.87
  • Day Low29.20
  • Prev Close30.14
  • 52 Week High32.96
  • 52 Week High Date01/24/23
  • 52 Week Low8.80
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap844.62M
  • Shares Out28.02M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change40.32

KEY STATS

  • Open29.58
  • Day High30.87
  • Day Low29.20
  • Prev Close30.14
  • 52 Week High32.96
  • 52 Week High Date01/24/23
  • 52 Week Low8.80
  • 52 Week Low Date06/14/22
  • Market Cap844.62M
  • Shares Out28.02M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change40.32

RATIOS/PROFITABILITY

  • EPS (TTM)-4.90
  • P/E (TTM)-6.16
  • Fwd P/E (NTM)-4.88
  • EBITDA (TTM)-132.567M
  • ROE (TTM)-73.59%
  • Revenue (TTM)136,999.995
  • Gross Margin (TTM)91.97%
  • Net Margin (TTM)-100,052.60%
  • Debt To Equity (MRQ)72.21%

EVENTS

  • Earnings Date03/08/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioXcel Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The Company’s commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. BXCL501 is also being developed for the acute...
Peter Mueller Ph.D.
Independent Chairman of the Board
Vimal Mehta Ph.D.
President, Chief Executive Officer, Director
Richard Steinhart
Chief Financial Officer, Senior Vice President
Address
555 Long Wharf Dr
New Haven, CT
06511-6107
United States

Top Peers

SYMBOLLASTCHG%CHG
KURA
Kura Oncology Inc
13.72UNCHUNCH
SANA
Sana Biotechnology Inc
4.92UNCHUNCH
AVXL
Anavex Life Sciences Corp
11.37UNCHUNCH
JANX
Janux Therapeutics Inc
21.84UNCHUNCH
RAPT
Rapt Therapeutics Inc
28.26UNCHUNCH